In vivo genome editing using Staphylococcus aureus Cas9
The RNA-guided endonuclease Cas9 has emerged as a versatile genome-editing platform. However, the size of the commonly used Cas9 from Streptococcus pyogenes (SpCas9) limits its utility for basic research and therapeutic applications that use the highly versatile adeno-associated virus (AAV) delivery...
Similar Items
-
Crystal Structure of Staphylococcus aureus Cas9
by: Nishimasu, Hiroshi, et al.
Published: (2017) -
Engineering of CRISPR-Cas12b for human genome editing
by: Jonathan Strecker, et al.
Published: (2019-01-01) -
A Survey of Genome Editing Activity for 16 Cas12a Orthologs
by: Zetsche, Bernd, et al.
Published: (2021) -
A Survey of Genome Editing Activity for 16 Cas12a Orthologs
by: Zetsche, Bernd, et al.
Published: (2022) -
Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems
by: Mohanraju, Prarthana, et al.
Published: (2018)